Skip to main content
Premium Trial:

Request an Annual Quote

Hundreds of Millions More to Share

President Joe Biden has announced the US will be purchasing hundreds of millions of SARS-CoV-2 vaccine doses to donate to other countries, the Washington Post reports.

Previously, the Biden Administration said in May it would be sharing millions of SARS-CoV-2 vaccine doses with other countries and in June said it was buying 500 million doses of the Pfizer-BioNTech vaccine with plans of distributing 200 million doses this year and the rest in the first half of next year through COVAX, as the Post reported at the time. In early August, it said it was set to send 110 million SARS-CoV-2 vaccine doses abroad. Global health experts, though, told NPR at the time that billions of doses were needed.

This new announcement, timed to the UN General Assembly, doubles the number of Pfizer-BioNTech vaccine doses the US is buying to share globally, the Associated Press says, adding Biden has also embraced a goal set by aid groups to vaccinate 70 percent of the global population within a year. "To beat the pandemic here, we need to beat it everywhere," Biden said, according to the AP.

However, the AP notes that only 15 percent of promised vaccine donations from wealthy countries have been delivered and that COVAX has missed most of its sharing targets.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.